Minoryx raises €51 million in a round co-led by Columbus Venture Partners and Caixa Capital Risc to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

by Caixa Capital Risc

The round was co-led by Columbus Venture Partners and Caixa Capital Risc. Dr. Damià Tormo, representing Columbus Venture Partners, has joined Minoryx’s Board of Directors. CDTI, through its Innvier...

Read more

Barbara IoT raises 2.5 M€ in funding from Caixa Capital Risc, Iberdrola and GoHub

by Caixa Capital Risc

Caixa Capital Risc, the venture capital arm of CriteriaCaixa and lead investor through its Criteria Venture Tech fund, and Iberdrola, through Perseo, its start-ups program for start-ups to promote the...

Read more

Vifor Pharma to acquire Sanifit, supported, among other investors, by Ysios Capital, Caixa Capital Risc, Columbus Venture Partners and Alta Life Sciences

by Caixa Capital Risc

Under the terms of the acquisition agreement, Vifor Pharma will acquire 100% of the outstanding shares in Sanifit Therapeutics, receiving full global rights for SNF472, further enhancing the company

Read more

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

by Asabys Partners

Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors And...

Read more

Splice Bio, backed by Ysios Capital, Asabys Partners and Caixa Capital Risc, appoints Jean-Philippe Combal as Chairman of the Board of Directors

by Caixa Capital Risc

Splice Bio, a gene therapy company based on technology developed in the Muir Lab at Princeton University, announced today that it has appointed JeanPhilippe Combal as Chairman of its Board of Director...

Read more

Caixa Capital Risc strengthens its commitment to the cybersecurity business by acquiring a stake in start-up company Build38 and searches for success cases of emerging companies

by Caixa Capital Risc

Caixa Capital Risc, through its ICT investment division, has acquired a stake in German start-up Build38. The deal has been carried out through a 3 million euros capital increase, which has been subsc...

Read more

European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases

by Ysios Capital

Minoryx is backed by a syndicate of experienced investors, which includes Caixa Capital Risc, Roche Venture Fund, Ysios Capital, Kurma Partners, Fund+, Chiesi Ventures, S.R.I.W, Idinvest, SFPI-FPIM, H...

Read more

ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio

by Ysios Capital

Splice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, has announced a new investment into the Company led by Ysios Capital and joined by Asabys Partners ...

Read more

Caixa Capital Risc takes the award for the best Venture Capital deal of the year for the sale of PlayGiga to Facebook

by Caixa Capital Risc

Before the sale, Caixa Capital Risc was the second largest shareholder of the company, which offers a streaming video game service, with a 20% shareholding. The arrival of Caixa Capital Risc, along wi...

Read more

Caixa Capital Risc invests in MealFood Europe, the leading start-up in the industrial insect production sector in Spain

by Caixa Capital Risc

Caixa Capital Risc, together with the CDTI investment vehicle Innvierte Sustainable Economy, have reached an agreement with the shareholders of MealFood Europe to enter the capital of the leading star...

Read more

Appentra raises €1.8m co-led by Armilar Venture Partners and K Fund for its Parallelware Analyzer software

by Xesgalicia

Appentra is excited to announce that Appentra has raised €1.8M in a round led by Armilar Venture Partners and K Fund, also joined by Caixa Capital Risc, Xesgalicia and Unirisco, the investors that h...

Read more

La Caixa y Caixa Capital Risc acercan al mercado a través de CaixaImpulse Consolidate cuatro iniciativas biomédicas disruptivas

by Caixa Capital Risc

La convocatoria Consolidate está permanentemente abierta y tiene previsto llevar a cabo dos o tres cortes al año para seleccionar las mejores candidaturas. La convocatoria otorgará entre tres y cin...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

El CDTI Innovación invierte, junto con ...

by Moira Capital Partners

THE WISE SEEKER S.L.es una start-up fundada en 2018 por profesionales ...

Photos Stream